Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Downgrades NeoGenomics to Hold

Needham Downgrades NeoGenomics to Hold

Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.

byBenzinga Newsdesk

August 22, 2022

1 minute read

Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.

M&A
News

Con Edison Divests Clean Energy Businesses To RWE For $6.8B

By Shivani Kumaresan

October 3, 8:11 AM

Consolidated Edison Inc (NYSE:ED) has entered into a purchase and sale agreement to sell its clean energy business and its subsidiaries…

AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement

By Nabaparna Bhattacharya

April 2, 8:51 AM

AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company.

ANGO

Analyst Ratings

In-Depth Examination Of 8 Analyst Recommendations For Five9

By Benzinga Insights

February 15, 9:00 AM

In the latest quarter, 8 analysts provided ratings for Five9 (NASDAQ:FIVN), showcasing a mix of bullish and bearish…

FIVN

$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today

By Benzinga Insights

August 1, 1:05 PM

Hershey (NYSE:HSY) has outperformed the market over the past 20 years by 1.69% on an annualized basis producing an average annual return of 9.54%. Currently, Hershey has a market capitalization of $46.97 billion.

HSY

Needham Downgrades NeoGenomics to Hold

Related Posts

Con Edison Divests Clean Energy Businesses To RWE For $6.8B

AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement

In-Depth Examination Of 8 Analyst Recommendations For Five9

$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today